Managed by Luc Ardouvin, Herbarom Group is positioned as a leader in natural ingredients and nutraceutical processing with two entities:
Herbarom Laboratoire produces essential oils and plant extracts with historical chains of aromatic plants from its home region Drôme (lavender, chamomile, angelica etc.) for the cosmetic, animal and human health sectors. The company offers tailor-made active ingredients and innovative concepts, rapidly available on the market.
Phytéo Laboratoire, nutraceutical contract manufacturing, this entity is the undisputed leader in liquid and dry galenic forms with a unique quality by offering its sourcing of plant solutions from Herbarom Laboratoire.
The ambition of Herbarom Group is to become a European leader in natural ingredients and nutraceuticals through an ambitious strategy of organic and external growth. Herbarom has already made three acquisitions in the last five years, the last one in 2021, Akémia bio. Today, the Group has a revenue of more than €50 million.
Eager to support a Group with unique expertise positioned in high-growth markets and firmly anchored in its home region of the Drôme, BPI France and BNP Paribas Développement have taken a minority interest in the company to support its growth strategy. In addition to a financial support, the two leading institutional investors also bring a powerful French and international network.